Recombinant T Cell Receptor Molecules Can Prevent and Reverse Experimental Autoimmune Encephalomyelitis Dose Effects and Involvement of Both CD4 and CD8 T Cells

Journal of Immunology

Volumn 159, Issue 10, 1997, Pages 5150-5156

  Kumar, Vipin ^a,c   Coulsell, Eric ^a   Ober, Bertram ^b   Hubbard, Greg ^b   Sercarz, Eli ^a   Ward, E Sally ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; LYMPHOCYTE ANTIGEN RECEPTOR; MYELIN BASIC PROTEIN; PEPTIDE FRAGMENT; RECOMBINANT PROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL; ARTICLE; C57BL MOUSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; DOSE RESPONSE; FEMALE; GENETICS; IMMUNOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE; PROTEIN TERTIARY STRUCTURE; SITE DIRECTED MUTAGENESIS;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; IMMUNODOMINANT EPITOPES; INJECTIONS, INTRAPERITONEAL; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MUTAGENESIS, SITE-DIRECTED; MYELIN BASIC PROTEINS; PEPTIDE FRAGMENTS; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECOMBINANT PROTEINS;

EID: 0031573087     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Paterson, P. Y. 1981. Multiple sclerosis: an immunological reassessment. J. Chronic Dis. 26:119.
2. Acha-Orbea, H., D. J. Mitchell, L. Timmermann, D. C. Wraith, G. S. Tausch, M. K. Waldor, S. S. Zamvil, H. O. McDevitt, and L. Steinman. 1988. Limited heterogeneity of T-cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention. Cell 54:263.
3. Urban, J. L., V. Kumar, D. H. Kono, C. Gomez, S. J. Horvath, J. Clayton, D. G. Ando, E. E. Sercarz, and L. Hood. 1988. Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy. Cell 54:577.
4. Burns, F. R., X. B. Li, N. Shen, H. Offner, Y. K. Chou, A. A. Vandenbark, and E. Heber-Katz. 1989. Both rat and mouse T cell receptors specific for the encephalitogenic determinant of myelin basic protein use similar Vα and Vβ chain genes. J. Exp. Med. 169:27.
5. Wucherpfennig, K. W., and D. A. Hafler. 1995. A review of T cell receptors in multiple sclerosis: clonal expansion and persistence of human T cells specific for an immunodominant myelin basic protein peptide. Ann. NY Acad. Sci. 756:241.
6. Oksenberg, J. R., M. A. Panzara, A. B. Begovich, D. Mitchell, H. A. Erlich, R. S. Murray, R. Shimonkevitz, M. Sherritt, J. Rothbard, and C. C. Bernard. 1993. Selection of T cell receptor V-D-J gene rearrangements with specificity for a MBP peptide in brain lesions of MS. Nature 362:68.
7. Vandevyver, C., N. Mertens, P. van den Elsen, R. Medaer, J. Raus, and J. Zhang. 1995. Clonal expansion of myelin basic protein-reactive T cells in patients with multiple sclerosis: restricted TCR V gene rearrangements and CDR3 sequence. Eur. J. Immunol. 25:958.
8. Allegretta, M., and L. Steinman. 1995. Unique T cell receptor junctional sequences found in multiple sclerosis and T cells mediating experimental allergic encephalomyelitis. Ann. NY Acad. Sci. 756:265.
9. Steinman, L. 1993. Autoimmune disease. Sci. Am. 269:106.
10. Cohen, I. R. 1995. Treatment of autoimmune disease: to activate or to deactivate? Chem. Immunol. 60:150.
11. -/- mice. Science 256:1210.
12. Lafaille, J. J., K. Nagashima, M. Katsuki, and S. Tonegawa. 1994. High incidence of spontaneous autoimmune encephalomyelitis in immunodelicient anti-myelin basic protein T cell receptor transgenic mice. Cell 78:399.
13. Vandenbark, A. A., G. Hashim, and H. Offner. 1989. Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis. Nature 341:541.
14. Howell, M. D., S. T. Winters, T. Olee, H. C. Powell, D. J. Carlo, and S. W. Brostoff. 1989. Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides. Science 246:668.
15. + T cells in recovery from antigen-induced autoimmune disease. J. Exp. Med. 178:909.
16. Gaur, A., R. Haspel, P. J. Mayer, and C. G. Fathman. 1993. Requirement for CD8+ cells in T cell receptor peptide-induced clonal unreponsiveness. Science 259:91.
17. Ward, E. S. 1992. Secretion of T cell receptor fragments from recombinant Escherichia coli cells. J. Mol. Biol. 224:885.
18. Fields, B. A., B. Ober, E. L. Malchiodi, M. I. Lebedeva, B. C. Braden, X. Ysern, J. K. Kim, X. Shao, E. S. Ward, and R. A. Mariuzza. 1995. Crystal structure of the Vα domain of a T cell antigen receptor. Science 270:1821.
19. Wraith, D. C., D. E. Smilek, D. J. Mitchell, L. Steinman, and H. O. McDevitt. 1989. Antigen recognition in autoimmune encephalomyelitis and the potential for peptide mediated therapy. Cell 59:247.
20. Wraith, D. C., B. Brunn, and P. J. Fairchild. 1992. Cross reactive antigen recognition by an encephalitogenic TCR: implications for T cell biology and autoimmunity. J. Immunol. 149:3765.
21. Myers, L. K., E. F. Rosloniec, J. Seyer, J. M. Stuart, and A. H. Kang. 1993. A synthetic peptide analogue of a determinant of type II collagen prevents the onset of collagen-induced arthritis. J. Immunol. 150:4652.
22. Chien, Y.-H., N. R. J. Gascoigne, J. Kavaler, N. E. Lee, and M. M. Davis. 1993. Somatic recombination in a murine T cell receptor gene. Nature 309:322.
23. Kumar, V., R. Tabibiazar, H. M. Geysen, and E. Sercarz. 1995. The dominant self-TCR peptide from the framework III region of the β-chain controls murine EAE. J. Immunol. 154:1941.
24. Vainiene, M., B. Celnik, A. A. Vandenbark, G. A. Hashim, and H. Offner. 1996. Natural immunodominant and experimental autoimmune encephalomyelitis-protective determinants within the Lewis rat V beta 8.2 sequence include CDR2 and framework 3 idiotopes. J. Neurosci. Res. 43:137.
25. Ciubotaru, M., and E. S. Ward. 1994. Expression of soluble T cell receptor fragments derived from a T cell clone associated with murine collagen-induced arthritis. Immunol. Lett. 43:139.
26. Aichele, P., K. Brduscha-Riem, R. M. Zinkernagel, H. Hengartner, and H. Pircher. 1995. T cell priming versus T cell tolerance induced by synthetic peptides. J. Exp. Med. 182:261.
27. Linton, P. J., A. Rudie, and N. R. Klinman. 1991. Tolerance susceptibility of newly generating memory B cells. J. Immunol. 146:4099.
28. Desquenne-Clark, L., T. R. Esch, L. Otvos, and E. Heber-Katz. 1991. Studies of V beta 8 T cell receptor peptide treatment in experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 88:7719.
29. Ishioka, G. Y., L. Adorini, J. C. Guery, F. C. Gaeta, R. LaFond, J. Alexander, M. F. Powell, A. Sette, and H. M. Grey. 1994. Failure to demonstrate long-lived MHC saturation both in vitro and in vivo: implications for therapeutic potential of MHC-blocking peptides. J. Immunol. 152:4310.
30. Germain, R. N. 1994. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 76:287.
31. Chunduru, S. K., R. M. Sutherland, G. A. Stewart, R. W. Doms, and Y. Paterson. 1996. Exploitation of the V beta 8.2 T cell receptor in protection against experimental autoimmune encephalomyelitis using a live vaccinia virus vector. J. Immunol. 156:4940.
32. Kumar, V., and E. Sercarz. 1996. Genetic vaccination: the advantages of going naked. Nat. Med. 2:857.
33. Waisman, A., P. J. Ruiz, D. L. Hirschberg, A. Gelman, J. R. Oksenberg, S. Brocke, F. Mor, I. R. Cohen, and L. Steinman. 1996. Suppressive vaccination with DNA encoding a variable region gene of the T cell receptor prevents autoimmune encephalomyelitis and activates Th2 immunity. Nat. Med. 2:899.
34. Lehmann, P. V., T. Forsthuber, A. Miller, and E. Sercarz. 1992. Determinant spreading in autoimmunity: cryptic T-cell determinants of myelin basic protein become immunogenic after immunization with a dominant peptide of the molecule. Nature 358:155.
35. Brocke, S., K. Gijbels, M. Allegretta, I. Ferber, C. Piercy, T. Blankenstein, R. Martin, U. Utz, N. Karin, D. Mitchell, T. Veromaa, A. Waisman, A. Gaur, P. Conlon, N. Ling, P. J. Fairchild, D. C. Wraith, A. O'Garra, C. G. Fathman, and L. Steinman. 1996. Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein. Nature 379:343.
36. Arden, B., S. P. Clark, D. Kabelitz, and T. W. Mak. 1995. Mouse T-cell receptor variable gene segment families. Immunogenetics 42:501.